Sun Pharma, India’s largest pharmaceutical company, is trading near ₹1,582 as of September 5, 2025. Analysts project a 2025 price target range of ₹1,525 to ₹2,050, with the base case leaning toward ₹1,900–₹2,000. Technical charts highlight strong support at ₹1,550 and resistance around ₹1,647–₹1,700, making the ₹1,600 level crucial for upcoming moves. With strong fundamentals,…
Sun Pharmaceutical Industries Ltd is one of India’s largest and most respected pharmaceutical companies. Founded in 1983, it specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generic medicines, branded formulations, and over-the-counter drugs. The company focuses on high-quality, affordable medications, helping to improve healthcare for people worldwide. Sun…
Sun Pharma Share Price Target 2025:- Sun Pharma is one of India’s leading pharmaceutical companies, known for its strong presence in the global generics and specialty drug markets. The company’s share price target for 2025 will depend on several factors, including new product launches, regulatory approvals, and expansion in key markets like the U.S. and…